BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16305472)

  • 1. Chelators as antidotes of metal toxicity: therapeutic and experimental aspects.
    Blanusa M; Varnai VM; Piasek M; Kostial K
    Curr Med Chem; 2005; 12(23):2771-94. PubMed ID: 16305472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chelation in metal intoxication--Principles and paradigms.
    Aaseth J; Skaug MA; Cao Y; Andersen O
    J Trace Elem Med Biol; 2015; 31():260-6. PubMed ID: 25457281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal chelators and neurotoxicity: lead, mercury, and arsenic.
    Bjørklund G; Mutter J; Aaseth J
    Arch Toxicol; 2017 Dec; 91(12):3787-3797. PubMed ID: 29063135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention by chelating agents of metal-induced developmental toxicity.
    Domingo JL
    Reprod Toxicol; 1995; 9(2):105-13. PubMed ID: 7795320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chelators on mercury, iron, and lead neurotoxicity in cortical culture.
    Rush T; Hjelmhaug J; Lobner D
    Neurotoxicology; 2009 Jan; 30(1):47-51. PubMed ID: 19027035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic and lead induced free radical generation and their reversibility following chelation.
    Flora SJ; Flora G; Saxena G; Mishra M
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advance in the therapy of metal poisonings with chelating agents.
    Aaseth J
    Hum Toxicol; 1983 Apr; 2(2):257-72. PubMed ID: 6345341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
    Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
    Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heavy metal induced oxidative stress & its possible reversal by chelation therapy.
    Flora SJ; Mittal M; Mehta A
    Indian J Med Res; 2008 Oct; 128(4):501-23. PubMed ID: 19106443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of chelation in the treatment of arsenic and mercury poisoning.
    Kosnett MJ
    J Med Toxicol; 2013 Dec; 9(4):347-54. PubMed ID: 24178900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning.
    Kalia K; Flora SJ
    J Occup Health; 2005 Jan; 47(1):1-21. PubMed ID: 15703449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of chelation in the treatment of other metal poisonings.
    Smith SW
    J Med Toxicol; 2013 Dec; 9(4):355-69. PubMed ID: 24113858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a therapeutic procedure for bismuth intoxication with chelating agents.
    Slikkerveer A; Jong HB; Helmich RB; de Wolff FA
    J Lab Clin Med; 1992 May; 119(5):529-37. PubMed ID: 1583409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of pitfalls and progress in chelation treatment of metal poisonings.
    Andersen O; Aaseth J
    J Trace Elem Med Biol; 2016 Dec; 38():74-80. PubMed ID: 27150911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
    Nogueira CW; Soares FA; Nascimento PC; Muller D; Rocha JB
    Toxicology; 2003 Mar; 184(2-3):85-95. PubMed ID: 12499112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal-induced developmental toxicity in mammals: a review.
    Domingo JL
    J Toxicol Environ Health; 1994 Jun; 42(2):123-41. PubMed ID: 8207750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
    Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
    Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
    Bhadauria S; Flora SJ
    Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.